EB8018 (First-in-class FimH blocker): Clinical Trials

1 completed. 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	1	Completed 1

Follow EB8018 (First-in-class FimH blocker): new trials by email Literature Review of EB8018 (First-in-class FimH blocker) trials Research Report on EB8018 (First-in-class FimH blocker)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients EB8018 (First-in-class FimH blocker) - Crohn Disease	Phase 1	Completed	Enterome	8	2018-03-07	2021-02-02

Conditions studied

Crohn Disease (1)

Sponsors

Enterome (1)

Countries

Austria (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)